2024 Annual Public Meeting of the Board of Directors
May 7, 2024
12:30pm-2pm (eastern)
(in-person and virtual attendance options)
Each year, the Reagan-Udall Foundation for the FDA conducts an annual public meeting to discuss its activities in support of the U.S. Food and Drug Administration.
The Foundation’s annual public meeting provides an opportunity for engagement between FDA and external stakeholders including patients and consumer advocates, regulated industry, health care providers, academics, and others dedicated to improving America's public health.
This year, attendees will be able to hear from Commissioner Robert M. Califf, MD, MACC, and several key agency leaders. The meeting will include a town hall-style discussion with an opportunity for attendees to submit questions. This is a hybrid event with options to attend virtually or in-person at Foundation headquarters at 1333 New Hampshire Ave. NW, Washington, DC (limited seating available).
Agenda
12:30PM |
Welcome and Opening RemarksRichard L. Schilsky, MD, FDA Foundation Board Chair |
---|---|
12:40PM |
FDA Priorities Panel DiscussionModerated by Susan C. Winckler, RPh, Esq. Jim Jones, MS, Deputy Commissioner for Human Foods, U.S. Food and Drug Administration |
1:30PM |
Commissioner Remarks with Q&ARobert M. Califf, MD, MACC, Commissioner of Food and Drugs, U.S. Food and Drug Administration |
1:55PM |
Conclude |